Akèy › Twoub Defisi Atansyon ak Ipèaktivite › Kentucky
Etid klinik pou Twoub Defisi Atansyon ak Ipèaktivite nan Kentucky
3 etid pou Twoub Defisi Atansyon ak Ipèaktivite ap chèche patisipan nan sit nan Kentucky.
Tèks ofisyèl etid la (Anglè)
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Kentucky Pediatric/Adult Research, Bardstown
- Qualmedica Research, LLC., Owensboro
Ap rekriteFaz 4
48 Months – 69 Months · Tout sèks · Mizajou Sep 11, 2026 · NCT04781140Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Bardstown
Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou Sep 8, 2026 · NCT07717879Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Bardstown
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 8, 2026 · NCT07717892Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.